BRILLIANCE BIOMEDICINE CO., LTD.
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
Development of 3D-printed medical devices for joint repair, as well as design and prototyping services for various types of 3D-printed medical devices. Our flagship product is a novel injectable composite artificial bone for spinal applications. It retains the advantages of bone cement injection while overcoming its drawbacks, serving as an alternative to traditional acrylic bone cement. By completely eliminating the high risks and severe complications associated with traditional acrylic bone cement, it rapidly and safely alleviates patient pain. This provides physicians and patients with a safer, more effective treatment option, establishing itself as the next-generation medical device for vertebral compression fracture surgeries.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2016
Unified Business No.
69554862
Status
Active
Number of Employees
0
Total Paid-in
Capital
3,550,000 (NT$)
Location of Company
Taiwan
, Taoyuan City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Our company's R&D team originated from Chung Yuan Christian University, primarily developing 3D-printed medical device products for joint repair, as well as design and trial manufacturing services for various types of 3D-printed medical devices. This project gathers the university's R&D capabilities and collaborates with domestic material manufacturers to independently manufacture repair scaffolds. This holds significant landmark significance for the domestic medical device industry, helps improve the medical quality of osteoarthritis treatment, and is expected to contribute to the treatment of the increasingly growing osteoarthritis disease in an aging society, as well as to the enhancement of patients' quality of life.
(The content above was translated by AI.)
(The content above was translated by AI.)
